HappeningToo topic
Ibrutinib reports
Browse community reports connected to Ibrutinib. These reports can show that other people are describing similar experiences, but they do not prove that Ibrutinib caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
32 problems
Abdominal Discomfort while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and abdominal discomfort appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and abdominal pain upper appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and abdominal pain appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and anxiety appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and back pain appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and constipation appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and cough appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and decreased appetite appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and dehydration appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and diarrhea appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and dizziness appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dry Skin while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and dry skin appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dyspepsia while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and dyspepsia appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and fatigue appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and feeling abnormal appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and headache appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and hypotension appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and insomnia appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and itching appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and malaise appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and muscle spasms appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and myalgia appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and nausea appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and pain appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Palpitations while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and palpitations appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and peripheral swelling appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and rash appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and shortness of breath appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and vomiting appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and weakness appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and weight decreased appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Ibrutinib
FDA FAERS contains adverse-event reports in which Ibrutinib and weight increased appear together. This does not establish that Ibrutinib caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →